190 related articles for article (PubMed ID: 31422204)
1. pDC depletion induced by CD317 blockade drives the antitumor immune response in head and neck squamous cell carcinoma.
Yang LL; Mao L; Wu H; Chen L; Deng WW; Xiao Y; Li H; Zhang L; Sun ZJ
Oral Oncol; 2019 Sep; 96():131-139. PubMed ID: 31422204
[TBL] [Abstract][Full Text] [Related]
2. CD317 Signature in Head and Neck Cancer Indicates Poor Prognosis.
Yang LL; Wu L; Yu GT; Zhang WF; Liu B; Sun ZJ
J Dent Res; 2018 Jul; 97(7):787-794. PubMed ID: 29486141
[TBL] [Abstract][Full Text] [Related]
3. Blockade of TIGIT/CD155 Signaling Reverses T-cell Exhaustion and Enhances Antitumor Capability in Head and Neck Squamous Cell Carcinoma.
Wu L; Mao L; Liu JF; Chen L; Yu GT; Yang LL; Wu H; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ
Cancer Immunol Res; 2019 Oct; 7(10):1700-1713. PubMed ID: 31387897
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia promotes the tolerogenic phenotype of plasmacytoid dendritic cells in head and neck squamous cell carcinoma.
Fan C; Wu J; Shen Y; Hu H; Wang Q; Mao Y; Ye B; Xiang M
Cancer Med; 2022 Feb; 11(4):922-930. PubMed ID: 34964283
[TBL] [Abstract][Full Text] [Related]
5. The cytokine milieu compromises functional capacity of tumor-infiltrating plasmacytoid dendritic cells in HPV-negative but not in HPV-positive HNSCC.
Koucký V; Hladíková K; Táborská E; Bouček J; Grega M; Špíšek R; Fialová A
Cancer Immunol Immunother; 2021 Sep; 70(9):2545-2557. PubMed ID: 33569630
[TBL] [Abstract][Full Text] [Related]
6. Blockade of adenosine A2A receptor enhances CD8
Ma SR; Deng WW; Liu JF; Mao L; Yu GT; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ
Mol Cancer; 2017 Jun; 16(1):99. PubMed ID: 28592285
[TBL] [Abstract][Full Text] [Related]
7. CD244 represents a new therapeutic target in head and neck squamous cell carcinoma.
Agresta L; Lehn M; Lampe K; Cantrell R; Hennies C; Szabo S; Wise-Draper T; Conforti L; Hoebe K; Janssen EM
J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32217758
[TBL] [Abstract][Full Text] [Related]
8. TIGIT/CD155 blockade enhances anti-PD-L1 therapy in head and neck squamous cell carcinoma by targeting myeloid-derived suppressor cells.
Mao L; Xiao Y; Yang QC; Yang SC; Yang LL; Sun ZJ
Oral Oncol; 2021 Oct; 121():105472. PubMed ID: 34333450
[TBL] [Abstract][Full Text] [Related]
9. The prognosis of head and neck squamous cell carcinoma related to immunosuppressive tumor microenvironment regulated by IL-6 signaling.
Tsai MS; Chen WC; Lu CH; Chen MF
Oral Oncol; 2019 Apr; 91():47-55. PubMed ID: 30926062
[TBL] [Abstract][Full Text] [Related]
10. Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancer.
Hartmann E; Wollenberg B; Rothenfusser S; Wagner M; Wellisch D; Mack B; Giese T; Gires O; Endres S; Hartmann G
Cancer Res; 2003 Oct; 63(19):6478-87. PubMed ID: 14559840
[TBL] [Abstract][Full Text] [Related]
11. Myeloid-derived suppressor cells and plasmacytoid dendritic cells are associated with oncogenesis of oral squamous cell carcinoma.
Kouketsu A; Haruka S; Kuroda K; Hitoshi M; Kensuke Y; Tsuyoshi S; Takahashi T; Hiroyuki K
J Oral Pathol Med; 2023 Jan; 52(1):9-19. PubMed ID: 36380437
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis of significant genes and immune cell infiltration in HPV-related head and neck squamous cell carcinoma.
Xu L; Jin Y; Qin X
Int Immunopharmacol; 2020 Oct; 87():106844. PubMed ID: 32738592
[TBL] [Abstract][Full Text] [Related]
13. The Tumor Milieu Promotes Functional Human Tumor-Resident Plasmacytoid Dendritic Cells in Humanized Mouse Models.
Maser IP; Hoves S; Bayer C; Heidkamp G; Nimmerjahn F; Eckmann J; Ries CH
Front Immunol; 2020; 11():2082. PubMed ID: 33013879
[TBL] [Abstract][Full Text] [Related]
14. Immune-checkpoint molecules on regulatory T-cells as a potential therapeutic target in head and neck squamous cell cancers.
Suzuki S; Ogawa T; Sano R; Takahara T; Inukai D; Akira S; Tsuchida H; Yoshikawa K; Ueda R; Tsuzuki T
Cancer Sci; 2020 Jun; 111(6):1943-1957. PubMed ID: 32304268
[TBL] [Abstract][Full Text] [Related]
15. Plasmacytoid dendritic cell subpopulations in head and neck squamous cell carcinoma.
Thiel A; Kesselring R; Pries R; Wittkopf N; Puzik A; Wollenberg B
Oncol Rep; 2011 Sep; 26(3):615-20. PubMed ID: 21687955
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of SRC family kinases facilitates anti-CTLA4 immunotherapy in head and neck squamous cell carcinoma.
Yu GT; Mao L; Wu L; Deng WW; Bu LL; Liu JF; Chen L; Yang LL; Wu H; Zhang WF; Sun ZJ
Cell Mol Life Sci; 2018 Nov; 75(22):4223-4234. PubMed ID: 29955905
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the BDCA2-DTR Transgenic Mouse Model in Chronic and Acute Inflammation.
Mandl M; Drechsler M; Jansen Y; Neideck C; Noels H; Faussner A; Soehnlein O; Weber C; Döring Y
PLoS One; 2015; 10(8):e0134176. PubMed ID: 26252890
[TBL] [Abstract][Full Text] [Related]
18. Characterization and Differentiation of the Tumor Microenvironment (TME) of Orthotopic and Subcutaneously Grown Head and Neck Squamous Cell Carcinoma (HNSCC) in Immunocompetent Mice.
Brand M; Laban S; Theodoraki MN; Doescher J; Hoffmann TK; Schuler PJ; Brunner C
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33383676
[TBL] [Abstract][Full Text] [Related]
19. Immunological network analysis in HPV associated head and neck squamous cancer and implications for disease prognosis.
Chen X; Yan B; Lou H; Shen Z; Tong F; Zhai A; Wei L; Zhang F
Mol Immunol; 2018 Apr; 96():28-36. PubMed ID: 29477933
[TBL] [Abstract][Full Text] [Related]
20. IL-10 in the microenvironment of HNSCC inhibits the CpG ODN induced IFN-α secretion of pDCs.
Bruchhage KL; Heinrichs S; Wollenberg B; Pries R
Oncol Lett; 2018 Mar; 15(3):3985-3990. PubMed ID: 29456743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
